BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)
Go back to BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)| (NASDAQ: FDMT) | Delayed: 11.65 -0.22 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.87 | 52 Week High | $ | |||
| Open | $11.93 | 52 Week Low | $ | |||
| Day High | $12.05 | P/E | N/A | |||
| Day Low | $11.34 | EPS | $ | |||
| Volume | 705,822 | |||||

